title: Secondary amyloidosis in Crohn's disease: treatment with tumour necrosis factor inhibitor.
authors.forename: M M
authors.initials: MM
authors.lastname: Boscá
authors.forename: C M
authors.initials: CM
authors.lastname: Pérez-Baylach
authors.forename: M A
authors.initials: MA
authors.lastname: Solis
authors.forename: R
authors.initials: R
authors.lastname: Antón
authors.forename: E
authors.initials: E
authors.lastname: Mayordomo
authors.forename: S
authors.initials: S
authors.lastname: Pons
authors.forename: M
authors.initials: M
authors.lastname: Mínguez
authors.forename: A
authors.initials: A
authors.lastname: Benages
mesh_terms: D000328:Adult; D000686:Amyloidosis / Q000188:drug therapy*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab